Page last updated: 2024-11-04

vorinostat and Bilharziasis

vorinostat has been researched along with Bilharziasis in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research Excerpts

ExcerptRelevanceReference
"Schistosomiasis is a major neglected parasitic disease that affects more than 265 million people worldwide and for which the control strategy consists of mass treatment with the only available drug, praziquantel."4.02Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis. ( Darwish, S; Erdmann, F; Ghazy, E; Heimburg, T; Jung, M; Lancelot, J; Pierce, R; Robaa, D; Romier, C; Schmidt, M; Schmidtkunz, K; Shaik, TB; Simoben, CV; Sippl, W; Truhn, A; Zeyen, P, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ghazy, E1
Heimburg, T1
Lancelot, J1
Zeyen, P1
Schmidtkunz, K1
Truhn, A1
Darwish, S1
Simoben, CV1
Shaik, TB1
Erdmann, F1
Schmidt, M1
Robaa, D1
Romier, C1
Jung, M1
Pierce, R1
Sippl, W1

Other Studies

1 other study available for vorinostat and Bilharziasis

ArticleYear
Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis.
    European journal of medicinal chemistry, 2021, Dec-05, Volume: 225

    Topics: Animals; Crystallography, X-Ray; Dose-Response Relationship, Drug; HEK293 Cells; Histone Deacetylase

2021